Charles Schwab
SPRB

Charles Schwab’s Spruce Biosciences SPRB Stock Holding History

Charles Schwab’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Buy
+5,896
New +$330K ﹤0.01% 3322
2024
Q3 		– Sell
-204
Closed -$7.92K – 3619
2024
Q2 		$7.92K Hold
204
– – ﹤0.01% 3620
2024
Q1 		$12K Hold
204
– – ﹤0.01% 3456
2023
Q4 		$44.8K Hold
204
– – ﹤0.01% 3414
2023
Q3 		$34.6K Hold
204
– – ﹤0.01% 3445
2023
Q2 		$32.9K Buy
+204
New +$34.1K ﹤0.01% 3487
2022
Q2 		– Sell
-246
Closed -$38K – 3664
2022
Q1 		$38K Hold
246
– – ﹤0.01% 3558
2021
Q4 		$83K Hold
246
– – ﹤0.01% 3459
2021
Q3 		$111K Sell
246
-330
-57% -$207K ﹤0.01% 3370
2021
Q2 		$485K Sell
576
-13
-2% -$13.9K ﹤0.01% 3176
2021
Q1 		$733K Buy
589
+51
+9% +$78.3K ﹤0.01% 2950
2020
Q4 		$981K Buy
+538
New +$892K ﹤0.01% 2782

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Charles Schwab's SPRB Position: Q2 2026 in Review

Charles Schwab opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 5,896 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #3322 among its holdings. This is a return to the name: Charles Schwab previously reported a position in SPRB as recently as Q2 2024.

Charles Schwab first reported a position in SPRB in Q4 2020 and has held it in 12 quarters since. The position peaked at $981K in Q4 2020. 63 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Charles Schwab held 5,896 shares of Spruce Biosciences worth $318K as of Q2 2026.
  • Spruce Biosciences was a new Charles Schwab position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3322 holding.
  • Charles Schwab first reported a position in Spruce Biosciences in Q4 2020 and has held it in 12 quarters since.
  • Charles Schwab's Spruce Biosciences position peaked at $981K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.